Pacelli Fabio, Bossola Maurizio, Rosa Fausto, Tortorelli Antonio Pio, Papa Valerio, Doglietto Giovanni Battista
Istituto di Clinica Chirurgica, Università Cattolica del Sacro Cuore, Largo A. Gemelli, 8, 00168 Rome, Italy.
Clin Nutr. 2008 Jun;27(3):398-407. doi: 10.1016/j.clnu.2008.03.002. Epub 2008 Apr 23.
OBJECTIVE & AIMS: The present study aimed at retrospectively evaluating the incidence of mortality and major and minor postoperative complications in patients who underwent surgery for gastric cancer between 2000 and 2006 stratified according to the preoperative percentage weight loss, serum albumin levels and body mass index (BMI).
One hundred and ninety-six patients affected by gastric cancer admitted to the Division of Digestive Surgery of the Catholic University of Rome between January 2000 and December 2006 were considered eligible and were included in the study. According to the weight loss, patients were divided into three groups: (1) 0-5%; (2) 5.1-10%; (3) >10%. On the basis of serum albumin levels, were divided into three groups: (1) <3.0 g/dl; (2) 3.0-3.4 g/dl; (3) >3.5 g/dl. According to BMI, were divided into four groups: (1) <18.5 kg/m(2); (2) 18.5-24.9 kg/m(2); (3) 25.0-29.9 kg/m(2); (4) >30.0 kg/m(2). Postoperative complications and mortality were reported. Complications were classified by objective criteria as major or minor, and as infectious or non-infectious.
The postoperative mortality was 0%. Major infectious complications occurred in 20 patients (10.2%), major non-infectious in 18 (9.2%), minor infectious in 21 (10.7%), whereas minor non-infectious complications were absent. The rate of major infectious, major non-infectious and minor infectious postoperative complications was similar in patients with absent or light weight loss (8.8%, 8.8%, 10.6%, respectively), mild weight loss (15.3%, 11.5%, 9.6%, respectively), or severe weight loss (6.4%, 6.4%, 12.9%, respectively). Similarly, the rate of postoperative complications did not differ between patients with serum albumin <3.0 g/dl (10.8%, 8.1%, 8.1%, respectively); between 3.0 and 3.4 (8.8%, 13.3%, 17.7%, respectively) or > or =3.5 g/dl (10.5%, 7.9%, 8,7%, respectively). According to BMI, the rate of postoperative complications was: 11.7%, 5.8%, and 5.8% for BMI <18.5 kg/m(2); 9.4%, 8.2%, and 11.7% for BMI between 18.5 and 24.9 kg/m(2); 10.7%, 10.7%, and 9.2% for BMI between 25 and 29.9 kg/m(2); 10.3%, 10.3% and 13.7% for BMI >30 kg/m(2). Then, we evaluated the postoperative morbidity only in patients who underwent total gastrectomy or distal subtotal gastrectomy associated with extended lymphadenectomy. In this group of patients, the rate of postoperative complications was comparable in patients with 0-5% (8.8%, 7.7%, 10%, respectively), 5.1-10% (14.6%, 9.7%, 9.7%, respectively), and >10% (7.1%, 7.1%, 14.3%, respectively) weight loss. Also stratifying the patients according to the serum albumin levels, the rate of postoperative complications did not differ significantly (serum albumin <3.0 g/dl: 14.8%, 11.1%, 14.8%, respectively; serum albumin between 3.0 and 3.4 g/dl: 6.2%, 12.5%, 15.6%, respectively; serum albumin > or =3.5 g/dl: 10.4%, 5.8%, 7.0%, respectively). According to BMI, the rate of postoperative complications was: 7.6%, 0%, and 7.6% for BMI <18.5 kg/m(2); 9.5%, 9.5%, and 11.1% for BMI between 18.5 and 24.9 kg/m(2); 12.5%, 8.3%, and 10.4% for BMI between 25 and 29.9 kg/m(2); 9.5%, 9.5% and 9.5% for BMI >30 kg/m(2).
The present study suggests that weight loss and hypoalbuminemia are not associated with an increased risk of mortality and morbidity in patients who underwent surgery for gastric cancer. This study may represent a stimulus for further studies aiming at evaluating the actual role of malnutrition in the development of postoperative complications in major abdominal surgery.
本研究旨在回顾性评估2000年至2006年间接受胃癌手术患者的死亡率、术后主要和次要并发症的发生率,并根据术前体重减轻百分比、血清白蛋白水平和体重指数(BMI)进行分层。
2000年1月至2006年12月期间入住罗马天主教大学消化外科的196例胃癌患者被认为符合条件并纳入研究。根据体重减轻情况,患者分为三组:(1)0 - 5%;(2)5.1 - 10%;(3)>10%。根据血清白蛋白水平,分为三组:(1)<3.0 g/dl;(2)3.0 - 3.4 g/dl;(3)>3.5 g/dl。根据BMI,分为四组:(1)<18.5 kg/m²;(2)18.5 - 24.9 kg/m²;(3)25.0 - 29.9 kg/m²;(4)>30.0 kg/m²。报告术后并发症和死亡率。并发症根据客观标准分为主要或次要,以及感染性或非感染性。
术后死亡率为0%。主要感染性并发症发生在20例患者(10.2%),主要非感染性并发症发生在18例(9.2%),次要感染性并发症发生在21例(10.7%),而次要非感染性并发症未出现。体重未减轻或轻度减轻(分别为8.8%、8.8%、10.6%)、中度体重减轻(分别为15.3%、11.5%、9.6%)或重度体重减轻(分别为6.4%、6.4%、12.9%)的患者中,主要感染性、主要非感染性和次要感染性术后并发症的发生率相似。同样,血清白蛋白<3.0 g/dl(分别为10.8%、8.1%、8.1%)、3.0至3.4(分别为8.8%、13.3%、17.7%)或≥3.5 g/dl(分别为10.5%、7.9%、8.7%)的患者之间,术后并发症发生率无差异。根据BMI,术后并发症发生率为:BMI<18.5 kg/m²时为11.7%、5.8%和5.8%;BMI在18.5至24.9 kg/m²之间时为9.4%、8.2%和11.7%;BMI在25至29.9 kg/m²之间时为10.7%、10.7%和9.2%;BMI>30 kg/m²时为10.3%、10.3%和13.7%。然后,我们仅评估了接受全胃切除术或远端次全胃切除术并扩大淋巴结清扫术患者的术后发病率。在这组患者中,体重减轻0 - 5%(分别为8.8%、7.7%、10%)、5.1 - 10%(分别为14.6%、9.7%、9.7%)和>10%(分别为7.1%、7.1%、14.3%)的患者术后并发症发生率相当。根据血清白蛋白水平对患者进行分层时,术后并发症发生率也无显著差异(血清白蛋白<3.0 g/dl:分别为14.8%、11.1%、14.8%;血清白蛋白在3.0至3.4 g/dl之间:分别为6.2%、12.5%、15.6%;血清白蛋白≥3.5 g/dl:分别为10.4%、5.8%、7.0%)。根据BMI,术后并发症发生率为:BMI<18.5 kg/m²时为7.6%、0%和7.6%;BMI在18.5至24.9 kg/m²之间时为9.5%、9.5%和11.1%;BMI在25至29.9 kg/m²之间时为12.5%、8.3%和10.4%;BMI>30 kg/m²时为9.5%、9.5%和9.5%。
本研究表明,体重减轻和低白蛋白血症与接受胃癌手术患者的死亡率和发病率增加无关。本研究可能会刺激进一步的研究,旨在评估营养不良在重大腹部手术术后并发症发生中的实际作用。